Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin
Authors:
- H. L. ElliottHEH. L. Elliott
- A. W. KelmanAKA. W. Kelman
- J. VincentJVJ. Vincent
- J. L. ReidJRJ. L. Reid
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 18 (1) , 123-129
Abstract
1. The pharmacokinetic and pharmacodynamic profiles of intravenous and oral doxazosin were investigated in 6 normotensive volunteers. 2. The pharmacokinetics of i.v. and oral doxazosin were fitted simultaneously and independently. The parameters derived were in good agreement with a mean elimination half-life of 539 .+-. 75 min, bioavailability of 0.65 .+-. 0.11 and clearance of 140 .+-. 26 ml/min. 3. Pharmacokinetic-pharmacodynamic modelling indicated that the sensitivities to oral and i.v. doxazosin in individual subjects were in good agreement. 4. Based on these findings it is unlikely that doxazosin metabolites contribute significantly to the pharmacodynamic profile of doxazosin.Keywords
This publication has 8 references indexed in Scilit:
- The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man.British Journal of Clinical Pharmacology, 1986
- Application of Pharmacokinetic-Pharmacodynamic Modelling for the Comparison of Quinazoline α-Adrenoceptor Agonists in Normotensive VolunteersJournal of Cardiovascular Pharmacology, 1985
- Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.British Journal of Clinical Pharmacology, 1984
- Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metaboliteJournal of Pharmacokinetics and Biopharmaceutics, 1983
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982
- Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979